# Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population

> **NCT07482046** · PHASE2,PHASE3 · COMPLETED · sponsor: **Taisho Pharmaceutical Indonesia** · enrollment: 37 (actual)

## Conditions studied

- Heat Stress
- Athletic Performance

## Interventions

- **DRUG:** Light blue gel with the trademark Counterpain COOL® (License Number: POM QD. 111 709 501) containing the active substance Menthol 4%.
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07482046
- **Lead sponsor:** Taisho Pharmaceutical Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-30
- **Primary completion:** 2023-10-20
- **Final completion:** 2023-12-31
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482046, "Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07482046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
